Emyria (ASX:EMD) NonCurrent Deferred Liabilities: A$0.00 Mil (As of Dec. 2025)


What is Emyria NonCurrent Deferred Liabilities?

Emyria ASX:EMD NonCurrent Deferred Liabilities is A$0.00 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Emyria's non-current deferred liabilities for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Emyria NonCurrent Deferred Liabilities Related Terms

Emyria NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Emyria's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emyria NonCurrent Deferred Liabilities Chart

Emyria Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Emyria Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
What does a NonCurrent Deferred Liabilities of A$0.00 Mil mean?
Emyria (ASX:EMD) has a NonCurrent Deferred Liabilities of A$0.00 Mil as of Dec. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Emyria and its competitors.
Is Emyria's NonCurrent Deferred Liabilities too high?
Emyria's current NonCurrent Deferred Liabilities is A$0.00 Mil.
How does Emyria's NonCurrent Deferred Liabilities compare to VEEV and BTSG?
Emyria's NonCurrent Deferred Liabilities of A$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Emyria and its competitors. Emyria's current NonCurrent Deferred Liabilities is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emyria stock overvalued right now?
Based on GuruFocus' analysis, Emyria (ASX:EMD) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.04 — trading 33.3% above its estimated fair value. The current NonCurrent Deferred Liabilities is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Emyria (ASX:EMD), the current NonCurrent Deferred Liabilities is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emyria Business Description

Other Exchanges Q84:Germany
Address D2, 661 Newcastle Street, PO Box 1442, Leederville, WA, AUS, 6007
Emyria Ltd operates a network of specialist medical clinics and uses purpose-built software and technology to gather clinical data from consenting patients. It operates in one segment of research and development.